Scottish Start-up UB Pharma to Deliver UPS Drug Targets
LONDON – A £9.3 million (US$14.43 million) publicly funded ubiquitin research program has overcome difficulties in drugging those key protein recycling targets, leading to the formation of UB Pharma Ltd., which has now set out to raise £4 million to £6 million to take the lead candidates through to the clinic.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter